Totals
- Total revenue
- $235,204,492
- Total expenses
- $230,968,624
- Contributions and grants received
- $35,533,265
- Grants paid
- $3,971,528
- Program service revenue
- $195,099,800
- Investment income
- $3,894,142
- Other revenue
- $677,285
- Total assets, end of year
- $188,812,448
- Total liabilities, end of year
- $68,196,230
- Net assets or fund balances, end of year
- $120,616,218
- Program services expenses (Part IX)
- $198,249,581
- Management and general expenses
- $32,719,043
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $198,249,581
Program services were 85.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$9,242,529
-
1e · Government grants (contributions)
$21,335,992
-
1f · All other contributions, gifts and grants
$4,954,744
-
2a · Program service revenue: PHARMACY
total $54,436,294 · related or exempt $54,436,294
-
2b · Program service revenue: BLOOD SERVICES
total $52,099,123 · related or exempt $52,099,123
-
2c · Program service revenue: DIAGNOSTIC LABORATORIES
total $46,842,987 · related or exempt $46,842,987
-
2d · Program service revenue: ORGAN AND TISSUE DONATION
total $22,696,296 · related or exempt $22,696,296
-
2e · Program service revenue: MEDICAL SERVICES
total $10,878,454 · related or exempt $10,878,454
-
2f · All other program service revenue
total $8,146,646 · related or exempt $7,440,711 · unrelated business $705,935
-
3 · Investment income
total $3,454,842 · excluded $3,454,842
-
6a · Gross rents
real property $30,000
-
6b · Less rental expenses
real property $46,589
-
6c · Rental income or loss
real property -$16,589
-
6d · Net rental income or loss
total -$16,589 · excluded -$16,589
-
7a · Gross sales of assets other than inventory
securities $5,060,805 · other assets $38,950
-
7b · Less cost or other basis and sales expenses
securities $4,609,633 · other assets $50,822
-
7c · Gain or loss
securities $451,172 · other assets -$11,872
-
7d · Net gain or loss
total $439,300 · excluded $439,300
-
11a · Other revenue: AFFILIATE SERVICE FEES
total $413,384 · excluded $413,384
-
11b · Other revenue: SHARED SERVICE FEE
total $156,221 · unrelated business $156,221
-
11c · Other revenue: ACQUIRED CASH RECEIPTS
total $110,000 · excluded $110,000
-
11d · All other revenue
total $14,269 · related or exempt $13,034 · excluded $1,235
-
11e · Other revenue, total
$693,874
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $3,945,278 · program services $3,945,278
-
2 · Grants to domestic individuals
total $26,250 · program services $26,250
-
5 · Compensation of officers, directors and key employees
total $4,124,800 · program services $1,791,264 · management and general $2,333,536
-
7 · Other salaries and wages
total $75,002,577 · program services $64,518,173 · management and general $10,484,404
-
8 · Pension plan contributions
total $3,834,959 · program services $3,249,713 · management and general $585,246
-
9 · Other employee benefits
total $11,531,699 · program services $9,689,576 · management and general $1,842,123
-
10 · Payroll taxes
total $5,212,633 · program services $4,350,626 · management and general $862,007
-
11b · Fees: legal
total $714,336 · program services $583,425 · management and general $130,911
-
11c · Fees: accounting
total $72,547 · program services $57,547 · management and general $15,000
-
11d · Fees: lobbying
total $8,348 · program services $8,348
-
11f · Fees: investment management
total $6,218 · management and general $6,218
-
11g · Fees: other
total $25,472,581 · program services $24,082,941 · management and general $1,389,640
-
12 · Advertising and promotion
total $529,110 · program services $169,809 · management and general $359,301
-
13 · Office expenses
total $455,627 · program services $431,568 · management and general $24,059
-
14 · Information technology
total $2,126,209 · program services $1,802,115 · management and general $324,094
-
15 · Royalties
total $15,641 · program services $15,641
-
16 · Occupancy
total $5,464,838 · program services $3,423,714 · management and general $2,041,124
-
17 · Travel
total $2,892,767 · program services $2,483,414 · management and general $409,353
-
19 · Conferences, conventions and meetings
total $564,962 · program services $458,597 · management and general $106,365
-
20 · Interest
total $14,863 · program services $11,450 · management and general $3,413
-
22 · Depreciation, depletion and amortization
total $4,857,747 · program services $3,433,989 · management and general $1,423,758
-
23 · Insurance
total $82,872 · program services $82,772 · management and general $100
-
24a · Other expenses: COST OF IMPORTED PROD
total $45,761,354 · program services $45,761,354
-
24b · Other expenses: MEDICAL LAB SUPPLIES
total $20,109,719 · program services $20,071,126 · management and general $38,593
-
24c · Other expenses: VERSITI SERVICES ALLOC
total $12,913,241 · program services $3,820,619 · management and general $9,092,622
-
24d · Other expenses: EQUIPMENT LEASE/MAINT
total $3,391,961 · program services $2,426,401 · management and general $965,560
-
24e · All other expenses
total $1,835,487 · program services $1,553,871 · management and general $281,616
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $1,225,979 · end of year $4,778,539
-
2 · Savings and temporary cash investments
beginning of year $0 · end of year $0
-
3 · Pledges and grants receivable
beginning of year $3,463,590 · end of year $2,528,124
-
4 · Accounts receivable
beginning of year $35,985,416 · end of year $38,464,994
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $9,531,534 · end of year $11,173,130
-
9 · Prepaid expenses and deferred charges
beginning of year $586,811 · end of year $1,181,467
-
10a · Land, buildings and equipment: cost or other basis
$125,187,571
-
10b · Land, buildings and equipment: accumulated depreciation
$84,378,942
-
10c · Land, buildings and equipment, net
beginning of year $31,100,051 · end of year $40,808,629
-
11 · Investments: publicly traded securities
beginning of year $40,113,083 · end of year $44,952,503
-
12 · Investments: other securities
beginning of year $17,881,849 · end of year $17,143,314
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $939,531 · end of year $25,991,764
-
15 · Other assets
beginning of year $1,035,640 · end of year $1,789,984
-
17 · Accounts payable and accrued expenses
beginning of year $18,514,949 · end of year $49,314,606
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $329,670 · end of year $3,602,994
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $7,891,714 · end of year $15,278,630
-
27 · Net assets without donor restrictions
beginning of year $115,127,151 · end of year $120,616,218
Mission and programs · 2023
Mission
VERSITI WISCONSIN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.
Activities or mission (Part I)
(SEE SCHEDULE O)
-
VERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVICES TO BLEEDING AND CLOTTING DISORDER PATIENTS AND THEIR FAMILIES. AS A COVERED ENTITY UNDER THE FEDERAL 340B DRUG DISCOUNT PROGRAM, VERSITI IS ELIGIBLE TO ACCESS CERTAIN SPECIALTY PHARMACEUTICALS AT DISCOUNTED PRICING. PHARMACEUTICAL NET INCOME IS PROGRAM INCOME AND FUNDS ARE RESTRICTED TO ACTIVITIES AND EXPENDITURES THAT FURTHER ELIGIBLE PROJECTS AND PROGRAM OBJECTIVES; INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, APPROVED GRANT RESEARCH AND OTHER COSTS. VERSITI PROVIDES THESE SPECIALTY PHARMACY PRODUCTS TO HOME CARE PATIENTS AND HOSPITAL SYSTEMS. DURING 2023, 14,889 VIALS OF SPECIALTY PHARMACY PRODUCTS WERE PROVIDED.
Expenses $48,514,048 · Grants $114,000 · Revenue $54,436,294
-
VERSITI RECRUITS VOLUNTEER BLOOD DONORS, COLLECTS, PROCESSES AND DISTRIBUTES BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND RELIABLE SUPPLY OF BLOOD FOR HOSPITALS AND OTHER BLOOD CENTERS SERVED. DURING 2023, 149,369 BLOOD UNITS WERE COLLECTED.
Expenses $43,276,164 · Grants $33,700 · Revenue $52,112,157
-
VERSITI RESEARCH ADVANCES THE SCIENTIFIC AND MEDICAL UNDERSTANDING OF BLOOD BIOLOGY AND BLOOD DISEASE TO IMPROVE HEALTH. DURING 2023, VERSITI HAD 34 INVESTIGATORS.
Expenses $36,936,818 · Grants $3,817,200
-
A. VERSITI WISCONSIN, INC. (VERSITI) PROVIDES CLINICAL DIAGNOSTIC TESTING SERVICES TO HOSPITALS, PHYSICIAN OFFICES AND OTHER REFERENCE LABORATORIES. DURING 2023, 140,128 TESTS WERE PERFORMED.B. VERSITI ORGAN AND TISSUE DONATION COMBINES PROCUREMENT SERVICES AND EDUCATION TO ENHANCE THE LIVES OF PATIENTS AND PROVIDES GUIDANCE TO THE FAMILIES OF POTENTIAL DONORS. DURING 2023, 354 ORGANS WERE TRANSPLANTED AND 522 MUSKULOSKELETAL DONORS WERE SEEN.C. VERSITI MEDICAL SERVICES PROVIDES MEDICAL AND THERAPEUTIC SERVICES IN PARTNERSHIP WITH LOCAL HOSPITALS. DURING 2023, 3,267 THERAPEUTIC PROCEDURES WERE PERFORMED.D. VERSITI DONOR TESTING LABORATORY PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR VERSITI AFFILIATES AND OTHER BLOOD CENTER PARTNERS.THE COMBINED TOTALS FOR DIAGNOSTIC LABORATORY, ORGAN AND TISSUE DONATION, MEDICAL SERVICES, AND DONOR TESTING LABORATORY ARE SUMMARIZED BELOW.
Expenses $69,522,551 · Grants $6,628 · Revenue $88,564,383
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Chris MiskelCHRIS MISKEL
PRESIDENT & CEO
- Total calculated
- $1,480,476
- From this org
- $598,543
- From related orgs
- $826,558
- Other
- $55,375
- Hours/week
- 21 + 34 related
Schedule J breakdown matched by us
- Base
- $322,350 + $445,147 related
- Bonus
- $266,252 + $367,682 related
- Other
- $9,941 + $13,729 related
- Deferred
- $9,450 + $13,050 related
- Nontaxable benefits
- $13,807 + $19,068 related
- Filer's total
- $621,800 + $858,676 related
-
Fred GeilfussFRED GEILFUSS
CHAIR; LEGAL ADVISOR
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
L Alan WhaleyL ALAN WHALEY
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Sherry HusaSHERRY HUSA
SECRETARY
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Ron MillerRON MILLER
TREASURER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Nicholas BauerNICHOLAS BAUER
BOARD MEMBER - AS OF 3/23
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Coreen Dicus-Johnson JDCOREEN DICUS-JOHNSON JD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
David Ginsburg MDDAVID GINSBURG MD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Cecelia GoreCECELIA GORE
BOARD MEMBER - AS OF 11/23
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Gail HansonGAIL HANSON
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Thomas Hauske JrTHOMAS HAUSKE JR
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Dale KentDALE KENT
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Robert H ManegoldROBERT H MANEGOLD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Jeffrey S McDonaldJEFFREY S MCDONALD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Maggey OplingerMAGGEY OPLINGER
BOARD MEMBER - AS OF 11/23
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
John PerrasJOHN PERRAS
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Kathy Thornton-BiasKATHY THORNTON-BIAS
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Greg WesleyGREG WESLEY
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Peter ZieglerPETER ZIEGLER
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 4 related
-
Bart ReuterBART REUTER
EVP & GENERAL COUNSEL
- Total calculated
- $785,165
- From this org
- $302,795
- From related orgs
- $418,145
- Other
- $64,225
- Hours/week
- 21 + 34 related
Schedule J breakdown matched by us
- Base
- $172,593 + $238,342 related
- Bonus
- $119,642 + $165,219 related
- Other
- $10,560 + $14,584 related
- Deferred
- $9,702 + $13,398 related
- Nontaxable benefits
- $17,272 + $23,853 related
- Filer's total
- $329,769 + $455,396 related
-
Anthony WatkinsANTHONY WATKINS
EVP & CHIEF FINANCIAL OFFICER
- Total calculated
- $781,954
- From this org
- $311,566
- From related orgs
- $430,257
- Other
- $40,131
- Hours/week
- 21 + 34 related
Schedule J breakdown matched by us
- Base
- $180,480 + $249,233 related
- Bonus
- $118,529 + $163,682 related
- Other
- $12,557 + $17,342 related
- Deferred
- $9,702 + $13,398 related
- Nontaxable benefits
- $7,153 + $9,878 related
- Filer's total
- $328,421 + $453,533 related
-
Brian BautistaBRIAN BAUTISTA
EVP & CHIEF OPERATING OFFICER
- Total calculated
- $741,795
- From this org
- $288,748
- From related orgs
- $398,745
- Other
- $54,302
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $190,552 + $263,140 related
- Bonus
- $89,158 + $123,123 related
- Other
- $9,038 + $12,482 related
- Deferred
- $8,323 + $11,493 related
- Nontaxable benefits
- $14,484 + $20,002 related
- Filer's total
- $311,555 + $430,240 related
-
Michael Deininger MDMICHAEL DEININGER MD
EVP & CHIEF SCIENTIFIC OFFICER
- Total calculated
- $683,113
- From this org
- $611,478
- From related orgs
- $32,182
- Other
- $39,453
- Hours/week
- 48 + 7 related
Schedule J breakdown matched by us
- Base
- $480,803 + $25,305 related
- Bonus
- $103,702 + $5,458 related
- Other
- $26,973 + $1,419 related
- Deferred
- $15,794 + $831 related
- Nontaxable benefits
- $21,687 + $1,141 related
- Filer's total
- $648,959 + $34,154 related
-
Gitesh DubalGITESH DUBAL
EVP & CHIEF MARKETING OFFICER
- Total calculated
- $677,152
- From this org
- $260,471
- From related orgs
- $359,696
- Other
- $56,985
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $155,708 + $215,023 related
- Bonus
- $94,822 + $130,944 related
- Other
- $9,941 + $13,729 related
- Deferred
- $9,450 + $13,050 related
- Nontaxable benefits
- $14,483 + $20,002 related
- Filer's total
- $284,404 + $392,748 related
-
Bradley PietzBRADLEY PIETZ
EVP & CHIEF LABORATORY OFFICER
- Total calculated
- $616,384
- From this org
- $232,428
- From related orgs
- $320,977
- Other
- $62,979
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $122,156 + $168,693 related
- Bonus
- $99,703 + $137,686 related
- Other
- $10,569 + $14,598 related
- Deferred
- $9,544 + $13,181 related
- Nontaxable benefits
- $16,907 + $23,347 related
- Filer's total
- $258,879 + $357,505 related
-
Barbara BryantBARBARA BRYANT
EVP & CHIEF MEDICAL OFFICER
- Total calculated
- $571,871
- From this org
- $546,023
- From related orgs
- $0
- Other
- $25,848
- Hours/week
- 50 + 5 related
Schedule J breakdown matched by us
- Base
- $509,725
- Bonus
- $18,210
- Other
- $18,088
- Deferred
- $23,100
- Nontaxable benefits
- $2,748
- Filer's total
- $571,871
-
James WeidnerJAMES WEIDNER
EVP & CHIEF HR OFFICER
- Total calculated
- $564,260
- From this org
- $214,033
- From related orgs
- $295,574
- Other
- $54,653
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $130,103 + $179,667 related
- Bonus
- $73,266 + $101,178 related
- Other
- $10,664 + $14,729 related
- Deferred
- $9,702 + $13,398 related
- Nontaxable benefits
- $13,252 + $18,301 related
- Filer's total
- $236,987 + $327,273 related
-
Alexandra PieperALEXANDRA PIEPER
VP & CHIEF QLT OFF - THRU 10/23
- Total calculated
- $563,684
- From this org
- $218,935
- From related orgs
- $302,345
- Other
- $42,404
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $89,792 + $124,000 related
- Bonus
- $33,075 + $45,675 related
- Other
- $96,068 + $132,670 related
- Deferred
- $6,785 + $9,370 related
- Nontaxable benefits
- $11,025 + $15,224 related
- Filer's total
- $236,745 + $326,939 related
-
Lynne BriggsLYNNE BRIGGS
VP & CHIEF INFORMATION OFFICER
- Total calculated
- $525,083
- From this org
- $199,119
- From related orgs
- $274,980
- Other
- $50,984
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $131,999 + $182,288 related
- Bonus
- $64,262 + $88,743 related
- Other
- $2,858 + $3,949 related
- Deferred
- $10,816 + $14,935 related
- Nontaxable benefits
- $10,599 + $14,634 related
- Filer's total
- $220,534 + $304,549 related
-
Jessica DrouillardJESSICA DROUILLARD
VP & CHIEF QLT OFF - AS OF 10/23
- Total calculated
- $178,272
- From this org
- $69,419
- From related orgs
- $95,865
- Other
- $12,988
- Hours/week
- 22 + 33 related
Schedule J breakdown matched by us
- Base
- $62,998 + $86,997 related
- Bonus
- $6,048 + $8,352 related
- Other
- $373 + $516 related
- Deferred
- $4,274 + $5,902 related
- Nontaxable benefits
- $1,182 + $1,630 related
- Filer's total
- $74,875 + $103,397 related
-
Matthew Anderson MDMATTHEW ANDERSON MD
VP & DIAGNOSTIC LAB MED DIRECTOR
- Total calculated
- $513,613
- From this org
- $449,993
- From related orgs
- $0
- Other
- $63,620
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $361,305
- Bonus
- $85,900
- Other
- $2,788
- Deferred
- $23,100
- Nontaxable benefits
- $40,520
- Filer's total
- $513,613
-
Peter Newman PhDPETER NEWMAN PHD
VP RESEARCH & ASSOC DIR BRI
- Total calculated
- $449,815
- From this org
- $410,742
- From related orgs
- $0
- Other
- $39,073
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $355,020
- Bonus
- $48,700
- Other
- $7,022
- Deferred
- $26,400
- Nontaxable benefits
- $12,673
- Filer's total
- $449,815
-
Karin HoffmeisterKARIN HOFFMEISTER
DEPUTY DIRECTOR VBRI
- Total calculated
- $416,494
- From this org
- $367,763
- From related orgs
- $0
- Other
- $48,731
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $330,999
- Bonus
- $31,900
- Other
- $4,864
- Deferred
- $14,373
- Nontaxable benefits
- $34,358
- Filer's total
- $416,494
-
Lynn M Malec MDLYNN M MALEC MD
SENIOR MEDICAL DIRECTOR
- Total calculated
- $413,364
- From this org
- $373,341
- From related orgs
- $0
- Other
- $40,023
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $350,667
- Bonus
- $18,600
- Other
- $4,074
- Deferred
- $19,732
- Nontaxable benefits
- $20,291
- Filer's total
- $413,364
-
Lisa Baumann KreuzigerLISA BAUMANN KREUZIGER
SENIOR MEDICAL DIRECTOR
- Total calculated
- $411,356
- From this org
- $371,996
- From related orgs
- $0
- Other
- $39,360
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $313,730
- Bonus
- $33,900
- Other
- $24,366
- Deferred
- $23,100
- Nontaxable benefits
- $16,260
- Filer's total
- $411,356
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · First-class or charter travel
- 1a · Personal services (maid, chauffeur, chef)
- 1b · Written policy on the line-1a expenses
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4a · Severance or change-of-control payment
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
Answered no
- 2 · Substantiation required before reimbursing expenses
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 1A
- CHARTER TRAVEL VERSITI WISCONSIN PAID FOR A CHARTERED FLIGHT FOR TWO LISTED INDIVIDUALS FOR BUSINESS PURPOSES. THE CHARTER TRAVEL IS NOT TREATED AS TAXABLE COMPENSATION. PERSONAL SERVICES VERSITI WISCONSIN PROVIDED MOVING EXPENSES FOR THE FOLLOWING EMPLOYEE: BARBARA BRYANT $7,372. THE MOVING EXPENSES ARE TREATED AS TAXABLE COMPENSATION.
- PART I, LINE 3
- TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI WISCONSIN HAS INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET.
- PART I, LINE 4A
- SEVERANCE PAYMENT AN INDIVIDUAL RECEIVED A SEVERANCE PAYMENT. THE SEVERANCE IS INCLUDED IN COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III).
- PART I, LINE 5A, 5B, 6A, 6B AND 7:
- NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION
$3,810,000
RESEARCH
-
PATIENT FINANCIAL ASSISTANCE
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
VERSITI BLOOD RESEARCH INSTITUTE FNDN
501(C)(3) · SUPPORTING · WI
Directly controlled by VERSITI
-
501(C)(3) · SUPPORTING · WI
-
501(C)(3) · BLOOD · IL
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · MI
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · IN
Directly controlled by VERSITI
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
RCRC INDEPENDENT REVIEW BOARD LLC
REVIEW BOARD · TX · income $5,189,837 · assets $4,177,498
Directly controlled by VERSITI WI
-
QUANTIGEN LLC
SPECIALTY LAB SERVICES · IN · income $4,255,773 · assets $24,383,750
Directly controlled by VERSITI WI
-
PEARL IRB LLC
REGULATORY AFFAIRS CONSULTING SERVICES · IN · income $706,815 · assets $12,213,527
Directly controlled by VERSITI WI
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
CENETRON DIAGNOSTICS LLC
C · LABS & TRIALS · TX · 100% owned · share of income $1,011,465 · share of assets $21,968,176 · controlled entity
Directly controlled by VERSITI WI
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 28 October 2024
- IRS schema version
- 2023v5.1
- Source object
- 202403039349301230
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.